Alberta Woman Dies From a Blood Clot Linked to AstraZeneca

Alberta Woman Dies From a Blood Clot Linked to AstraZeneca

On the same day Alberta tightened restrictions to try to stem its record-setting COVID-19 infection rate, the province is reporting its first death related to the Oxford-AstraZeneca vaccine. Alberta’s chief medical officer of health, Dr. Deena Hinshaw, confirmed an Alberta woman in her 50s died from a rare vaccine-induced, blood-clotting disorder after receiving the AZ shot. Hinshaw says it is Alberta’s second case and only death from so-called VITT — vaccine-induced immune thrombotic thrombocytopenia — out of more than 253,000 doses of AstraZeneca that have been administered in the province to date. A 54-year-old woman in Quebec also died in a VITT case last month. Hinshaw notes the risk of death or suffering severe outcomes from COVID remain far greater than the risk following AstraZeneca vaccine.

News of Canada’s second vaccine-induced death came hours after Alberta Premier Jason Kenney announced all students will move to online learning Friday — and for the next three weeks. He’s also closing restaurant patios, hair salons and tattoo parlours, along with dropping capacity of retail shops, outdoor gatherings, and places of worship. Kenney says if the exponential COVID growth continues, it would begin to push the outer limits of Alberta’s hospital capacity within weeks.

Photo Credit: CPAC via Netflix

 

After 9 Podcast - 91.5 The Beat